Chronic, noncommunicable diseases (NCDs) are steadily increasing around the world, and developing countries are bearing much of the cost with 80 percent of deaths occurring there. NCDs such as cardiovascular disease, cancer, diabetes and lung disorders are expected to cause three-quarters of the disease burden in low- and middle-income countries by 2030.
NCDs cause untold pain, suffering, disability and hardship for millions of people. In addition, the economic costs are staggering, both in terms of lost productivity and rising health care expenses. Unless action is taken to reduce the toll of NCDs, a World Bank study estimates NCDs will cost the global economy about $35 trillion from 2005 to 2030. A number of NIH research and research training programs are working to address these health issues.
Related research topics:
Top News
- NIH funds research network to reduce stroke in Africa
Nov / Dec 2016 Global Health Matters
- Fogarty awards $3.8M in exploratory grants for chronic disease and injury research
Fogarty news, November 3, 2016
- Grantee news: Mexico's soda tax could reduce diabetes, heart disease and health costs, new study [supported in part by Fogarty] finds
University of California San Francisco news, November 1, 2016
- Planning grants for global noncommunicable disease research centers announced by National Cancer Institute
NCI Center for Global Health news, September 21, 2016
- Q and A with Dr Alain Beaudet on the Global Alliance for Chronic Diseases
May / Jun 2016 Global Health Matters
- GACD to fund mental health research
Global Alliance for Chronic Diseases news, April 14, 2016
- Global Alliance for Chronic Diseases partners publish hypertension findings
Jan / Feb 2016 Global Health Matters
- The Global Alliance for Chronic Diseases: a partnership blossoms
Opinion by Fogarty Director Dr Roger I Glass
Jan / Feb 2016 Global Health Matters
- Profile: Fogarty Scholar Dr John Stanifer studies kidney disease in Tanzania
Jan / Feb 2016 Global Health Matters
- Research to guide practice: Enhancing HIV/AIDS platforms to address NCDs in low-resource settings
an NIH, PEPFAR, LMIC collaboration